DE69215125T2 - Kardioaktive Steroide - Google Patents

Kardioaktive Steroide

Info

Publication number
DE69215125T2
DE69215125T2 DE69215125T DE69215125T DE69215125T2 DE 69215125 T2 DE69215125 T2 DE 69215125T2 DE 69215125 T DE69215125 T DE 69215125T DE 69215125 T DE69215125 T DE 69215125T DE 69215125 T2 DE69215125 T2 DE 69215125T2
Authority
DE
Germany
Prior art keywords
cardioactive
steroids
cardioactive steroids
chem
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69215125T
Other languages
English (en)
Other versions
DE69215125D1 (de
Inventor
Giorgio Bertolini
Cesare Casagrande
Stefania Montanari
Gabriele Norcini
Francesco Santangelo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Application granted granted Critical
Publication of DE69215125D1 publication Critical patent/DE69215125D1/de
Publication of DE69215125T2 publication Critical patent/DE69215125T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001Lactones
    • C07J21/003Lactones at position 17
DE69215125T 1991-02-14 1992-02-11 Kardioaktive Steroide Expired - Fee Related DE69215125T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910380A IT1250410B (it) 1991-02-14 1991-02-14 Composti steroidei attivi sul sistema cardiovascolare

Publications (2)

Publication Number Publication Date
DE69215125D1 DE69215125D1 (de) 1996-12-19
DE69215125T2 true DE69215125T2 (de) 1997-06-12

Family

ID=11358571

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69215125T Expired - Fee Related DE69215125T2 (de) 1991-02-14 1992-02-11 Kardioaktive Steroide

Country Status (7)

Country Link
US (1) US5426179A (de)
EP (1) EP0499327B1 (de)
JP (1) JPH0565293A (de)
AT (1) ATE145213T1 (de)
DE (1) DE69215125T2 (de)
ES (1) ES2096014T3 (de)
IT (1) IT1250410B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4232681C2 (de) * 1992-09-29 1994-11-24 Sigma Tau Ind Farmaceuti 17-Phenyl- und 17-Furyl-14beta,5alpha-androstan- und androsten- Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
US5597806A (en) * 1995-05-09 1997-01-28 Merck & Co., Inc. Antifungal agents
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
AU2010245823B2 (en) 2009-05-06 2016-11-24 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
DK3664470T3 (da) 2018-12-05 2021-04-19 Sonova Ag Fremskaffelse af feedback om lydstyrken af egen stemme for en bruger af et høreapparat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968132A (en) * 1974-12-23 1976-07-06 Schering Corporation (17R)-Spiro-[androstane-17,1'-cyclobutan]-2'-ones, methods for their manufacture and intermediates useful therein
DE2546779A1 (de) * 1975-10-18 1977-04-28 Boehringer Mannheim Gmbh Neue 20.22-dihydro-cardenolid- glykoside
FR2451923A1 (fr) * 1979-03-22 1980-10-17 Roussel Uclaf Nouveaux derives steroides 7-alkyles, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
ES2096014T3 (es) 1997-03-01
EP0499327B1 (de) 1996-11-13
US5426179A (en) 1995-06-20
EP0499327A1 (de) 1992-08-19
JPH0565293A (ja) 1993-03-19
ITMI910380A1 (it) 1992-08-15
DE69215125D1 (de) 1996-12-19
ITMI910380A0 (it) 1991-02-14
IT1250410B (it) 1995-04-07
ATE145213T1 (de) 1996-11-15

Similar Documents

Publication Publication Date Title
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
IT1285770B1 (it) Composti corticoidei
NO20002676D0 (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
DE69214777T2 (de) Monolithisch integrierter Mikrowellenverstärker mit hoher Verstärkung
ATE145213T1 (de) Kardioaktive steroide
DE69119992D1 (de) 4-Amino-delta4-Steroide und ihre Verwendung als Inhibitoren von 5alpha-Reduktase
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
NO923461D0 (no) Heterocykliske steroidforbindelser
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
ITMI920076A1 (it) Composti steroidei 17-aril-sostituiti attivi sul sistema cardiovascolare
DE69302911T2 (de) 17-(Pyridazin-N-Oxyd)-substituierte Steroide mit cardiotonischer Wirksamkeit
DE69303063D1 (de) Gegentaktausgangsstufe für integrierten Verstärker
BR9407232A (pt) Compostos de tiocarbamoíla
DE69402846T2 (de) Funkzwischenverstärker
DE69020520D1 (de) 2,19-Methylenoxy- und 2,19-methylenthiogebrückte Steroide und ihre Verwendung als Inhibitoren von Aromatase und 19-Hydroxylase.
KR950007476U (ko) 반전 증폭기 이득 조정 회로
SE9300030D0 (sv) Novel colon- or ileum-specific steroid derivatives
GR1001405B (el) Ενώσεις 2-πιπεραζινόνης και η παραγωγή και η χρησιμοποίηση αυτών.
KR920019812U (ko) 지주체 장공용 어태치먼트(attachment)
KR950012717U (ko) 음성출력 증폭회로
KR920020365U (ko) 증폭기의 입력전류 보상회로
KR950012715U (ko) 차동 증폭기의 이득 조정 회로
FI934920A0 (fi) Gjutstycke, foerfarande foer dess framstaellning och anvaendning av det
LV10719A (lv) Heterocikliski steroidu savienojumi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee